Merck KGaA Targets $385 Million in Cost Cuts by 2014 as Geneva Protests Continue

Published: May 16, 2012

Germany's Merck KGaA specified the targets of its ongoing restructuring programme on Tuesday, saying it eyes 300 million euros ($385 million) in annual cost cuts at its prescription drugs unit by 2014. It said in a statement it would incur one-off costs of about 600 million euros related to the programme between this year and 2014.

Back to news